Pacific Biosciences Of California (PACB) EBIT Margin (2010 - 2026)
Pacific Biosciences Of California (PACB) posted EBIT Margin of 114.36% for Q2 2026, down 408.77% on a QoQ basis from 22.48% in Q1 2026, and down 157.0% year-over-year from 200.64% in Q2 2025.
Powered by 
Analysis
Pacific Biosciences Of California (PACB) EBIT Margin (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California has reported EBIT Margin for 17 years, with the latest figure at 114.36% in Q2 2026.
- On a quarterly basis, EBIT Margin fell 157.0% year-over-year to 114.36% in Q2 2026; TTM through Jun 2026 was 83.53%, a 35904.0% increase from a year earlier, with the FY2025 full-year figure at 346.15%, down 3818.0% from the prior year.
- EBIT Margin was 114.36% for Q2 2026 at Pacific Biosciences Of California, down from 22.48% in the prior quarter.
- The five-year high for EBIT Margin was 22.48% in Q1 2026, with the low at 1154.51% in Q1 2025.
- Average EBIT Margin over 5 years is 250.4%, with a median of 175.98% recorded in 2022.
- The sharpest annual moves came in 2025 and 2026: EBIT Margin tumbled 94487 bps in 2025, then jumped 113203 bps in 2026.
- Over 5 years, EBIT Margin stood at 318.37% in 2022, then soared by 53 bps to 150.02% in 2023, then plunged by 160 bps to 390.14% in 2024, then jumped by 76 bps to 92.28% in 2025, then decreased by 24 bps to 114.36% in 2026.
- The last three EBIT Margin figures came in at 114.36% (Q2 2026), 22.48% (Q1 2026), and 92.28% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 17.99% |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 23.64% |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | 21.14% |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | 12.24% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 23.13% |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 11.15% |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | 6.85% |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | -12.95% |
| 10 | Pacific Biosciences Of California | 400.74 Mn | 163.87 Mn | 12.64 Mn | -114.36% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -114.36% |
| Mar 31, 2026 | -22.48% |
| Dec 31, 2025 | -92.28% |
| Sep 30, 2025 | -101.13% |
| Jun 30, 2025 | -112.79% |
| Mar 31, 2025 | -1,154.51% |
| Dec 31, 2024 | -390.14% |
| Sep 30, 2024 | -160.32% |
| Jun 30, 2024 | -488.28% |
| Mar 31, 2024 | -209.64% |
| Dec 31, 2023 | -150.02% |
| Sep 30, 2023 | -148.12% |
| Jun 30, 2023 | -153.82% |
| Mar 31, 2023 | -234.58% |
| Dec 31, 2022 | -318.37% |
| Sep 30, 2022 | -230.94% |
| Jun 30, 2022 | -191.64% |
| Mar 31, 2022 | -233.69% |
| Dec 31, 2021 | -179.56% |
| Jun 30, 2021 | -122.75% |